A Study of A4368 in Healthy Subjects

See also
Status	Clinical Trial	Phase
Completed	`NCT02017236` - A Food Effect Phase I Study of the Volitinib in Healthy Subjects	Phase 1
Completed	`NCT03885778` - A Food Effect Study of Besifovir in Healthy Subjects	Phase 4
Not yet recruiting	`NCT06325761` - A Study to Evaluate the Food Effects on Pharmacokinetics of SY-5007 Tablets in Healthy Subjects	Phase 1

See also

Status

Clinical Trial

Phase

Completed

NCT02017236 - A Food Effect Phase I Study of the Volitinib in Healthy Subjects

Phase 1

Completed

NCT03885778 - A Food Effect Study of Besifovir in Healthy Subjects

Phase 4

Not yet recruiting

NCT06325761 - A Study to Evaluate the Food Effects on Pharmacokinetics of SY-5007 Tablets in Healthy Subjects

Phase 1

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT04932252
Study type	Interventional
Source	Autophagy Sciences, Inc.
Contact
Status	Completed
Phase	Phase 1
Start date	September 7, 2021
Completion date	July 25, 2022

A Study of A4368 in Healthy Subjects — A4368

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms